Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression

Journal of Pathology

Volumn 227, Issue 1, 2012, Pages 106-117

  Hughes, Katherine ^a   Wickenden, Julie A ^a   Allen, Judith E ^b   Watson, Christine J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acute phase response; Breast cancer; Inflammation; Involution; Macrophage; Mammary gland; Signalling; Stat3

Indexed keywords

ARGINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN; PROTEIN YM1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CHRONIC INFLAMMATION; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LACTATION; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

ACUTE-PHASE REACTION; ANIMALS; CELL COUNT; CELL DEATH; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE DELETION; IMMUNITY, INNATE; LACTATION; MACROPHAGE ACTIVATION; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MAST CELLS; MICE; MICE, KNOCKOUT; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION; WEANING; WOUND HEALING;

EID: 84859647855     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3961     Document Type: Article

References (48)

1. Kritikou EA, Sharkey A, Abell K, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003; 130: 3459-3468. (Pubitemid 37010009)
2. Tiffen PG, Omidvar N, Marquez-Almuina N, et al. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. Mol Endocrinol 2008; 22: 2677-2688.
3. Nguyen AV, Pollard JW. Transforming growth factor-β3 induces cell death during the first stage of mammary gland involution. Development 2000; 127: 3107-3118. (Pubitemid 30611903)
4. Chapman RS, Lourenco PC, Tonner E, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999; 13: 2604-2616. (Pubitemid 29489651)
5. Humphreys RC, Bierie B, Zhao L, et al. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 2002; 143: 3641-3650. (Pubitemid 34925741)
6. Kreuzaler PA, Staniszewska AD, Li W, et al. Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 2011; 13: 303-309.
7. Thangaraju M, Rudelius M, Bierie B, et al. C/EBPδ is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 2005; 132: 4675-4685. (Pubitemid 41685278)
8. Baxter FO, Came PJ, Abell K, et al. IKKβ/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 2006; 133: 3485-3494. (Pubitemid 44501850)
9. Watson CJ. Post-lactational mammary gland regression: molecular basis and implications for breast cancer. Expert Rev Mol Med 2006; 8: 1-15. (Pubitemid 46017703)
10. Schere-Levy C, Buggiano V, Quaglino A, et al. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 2003; 282: 35-47. (Pubitemid 36062610)
11. Pensa S, Watson CJ, Poli V. Stat3 and the inflammation/acute phase response in involution and breast cancer. J Mamm Gland Biol Neoplasia 2009; 14: 121-129.
12. Clarkson RW, Wayland MT, Lee J, et al. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 2004; 6: R92-109.
13. Stein T, Morris JS, Davies CR, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004; 6: R75-91.
14. Van Nguyen A, Pollard JW. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol 2002; 247: 11-25. (Pubitemid 34681162)
15. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development 2000; 127: 2269-2282. (Pubitemid 30386567)
16. Chua AC, Hodson LJ, Moldenhauer LM, et al. Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium. Development 2010; 137: 4229-4238.
17. Pollard JW, Hennighausen L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci USA 1994; 91: 9312-9316. (Pubitemid 24297904)
18. Lund LR, Romer J, Thomasset N, et al. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 1996; 122: 181-193. (Pubitemid 26038430)
19. Walker NI, Bennett RE, Kerr JF. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 1989; 185: 19-32. (Pubitemid 19172084)
20. O'Brien J, Lyons T, Monks J, et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010; 176: 1241-1255.
21. Monks J, Smith-Steinhart C, Kruk ER, et al. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod 2008; 78: 586-594. (Pubitemid 351469341)
22. Lilla JN, Werb Z. Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol 2010; 337: 124-133.
23. Lilla JN, Joshi RV, Craik CS, et al. Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution. J Biol Chem 2009; 284: 13792-13803.
24. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759. (Pubitemid 41400849)
25. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006; 6: 281-291.
26. Schedin P, O'Brien J, Rudolph M, et al. Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mamm Gland Biol Neoplasia 2007; 12: 71-82. (Pubitemid 46394927)
27. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. JMamm Gland Biol Neoplasia 2009; 14: 87-98.
28. Lyons TR, O'Brien J, Borges VF, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011; 17: 1109-1115.
29. Helewa M, Levesque P, Provencher D, et al. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 2002; 24: 164-180; quiz, 181-164.
30. Daling JR, Malone KE, Doody DR, et al. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 235-241. (Pubitemid 34326999)
31. Whiteman MK, Hillis SD, Curtis KM, et al. Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 2004; 104: 146-154. (Pubitemid 40458918)
32. Mignot L. [Cancer of the breast and pregnancy: the point of view of the breast cancer specialist]. Bull Cancer 2002; 89: 772-778.
33. Gwyn K, Theriault R. Breast cancer during pregnancy. Oncology (Williston Park) 2001; 15: 39-46; discussion, 46, 49-51.
34. Petrek JA. Breast cancer during pregnancy. Cancer 1994; 74: 518-527. (Pubitemid 24187670)
35. Johansson AL, Andersson TM, Hsieh CC, et al. Increased mortality in women with breast cancer detected during pregnancy and different periods post partum. Cancer Epidemiol Biomarkers Prev 2011; 20: 1865-1872.
36. Alonzi T, Maritano D, Gorgoni B, et al. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 2001; 21: 1621-1632. (Pubitemid 32156382)
37. Selbert S, Bentley DJ, Melton DW, et al. Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgen Res 1998; 7: 387-396. (Pubitemid 28542069)
38. Li W, Ferguson BJ, Khaled WT, et al. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci USA 2009; 106: 4725-4730.
39. Nair MG, Gallagher IJ, Taylor MD, et al. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 2005; 73: 385-394. (Pubitemid 40041131)
40. Anderson LH, Boulanger CA, Smith GH, et al. Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn 2011; 240: 674-681.
41. Khaled WT, Read EK, Nicholson SE, et al. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development 2007; 134: 2739-2750. (Pubitemid 47307230)
42. O'Donnell LC, Druhan LJ, Avalos BR. Molecular characterization and expression analysis of leucine-rich α2-glycoprotein, a novel marker of granulocytic differentiation. J Leukoc Biol 2002; 72: 478-485.
43. Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011; 73: 479-501.
44. Li M, Liu X, Robinson G, et al. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci USA 1997; 94: 3425-3430. (Pubitemid 27157328)
45. Recklies AD, Ling H, White C, et al. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 2005; 280: 41213-41221. (Pubitemid 41832176)
46. Lund LR, Bjorn SF, Sternlicht MD, et al. Lactational competence and involution of the mouse mammary gland require plasminogen. Development 2000; 127: 4481-4492.
47. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
48. Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996; 49: 20-37. (Pubitemid 26181735)